Baillie Gifford & Co
Source: SEC Form 13F · as of Mar 2026Baillie Gifford & Co holds 17 biotech & pharma companies tracked by BioSniper, totaling $2.04B in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$2.04B
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,493,866 | $825.1M |
| ELVElevance Health Inc. | 1,172,808 | $343.3M |
| PMPhilip Morris International Inc | 1,644,203 | $271.9M |
| UTHRUNITED THERAPEUTICS Corp | 428,127 | $253.9M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 199,421 | $89.0M |
| BNTXBioNTech SE | 882,572 | $78.4M |
| TWSTTwist Bioscience Corp | 1,215,151 | $57.7M |
| PRCTPROCEPT BioRobotics Corporation | 973,502 | $24.3M |
| PGNYProgyny Inc. | 1,220,729 | $20.7M |
| ZTSZoetis Inc. | 162,231 | $19.2M |
| STOKStoke Therapeutics, Inc. | 575,182 | $18.7M |
| RVMDREVOLUTION MEDICINES, INC. | 187,072 | $18.2M |
| BEAMBeam Therapeutics Inc. | 385,891 | $9.2M |
| SDGRSchrodinger, Inc. | 801,170 | $9.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 20,444 | $5.5M |
| NVONovo Nordisk A/S | 82 | $3K |
| ONCBeOne Medicines Ltd. | 5 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.